Elastrography forms the cornerstone of an ultrasound system unveiled by first-time RSNA exhibitor SuperSonic Imagine. The Aixplorer system is dedicated to breast imaging. It differentiates healthy from cancerous tissues by quantifying differences in the elasticity of the tissues. SuperSonic’s ShearWave Elastography technique produces consistent results regardless of the operator’s skill, according to the company.
Elastrography forms the cornerstone of an ultrasound system unveiled by first-time RSNA exhibitor SuperSonic Imagine. The Aixplorer system is dedicated to breast imaging. It differentiates healthy from cancerous tissues by quantifying differences in the elasticity of the tissues. SuperSonic's ShearWave Elastography technique produces consistent results regardless of the operator's skill, according to the company.
Jacques Souquet, Ph.D., former chief technology officer of ATL and later Philips Ultrasound, founded the company in April 2005 in Aix-en-Provence, France, the name source for the firm's new product. The company employs 92 people, including U.S. expatriates and French employees repatriated from the U.S.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.